Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images Postmenopause refers to the time period after the person finishes menopause and no longer has ...
Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...
IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...
The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...
INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...
Addyi is broadly accessible and affordable for most patients: women with insurance typically pay just $20 monthly, and for those paying cash, Addyi is available for $149 per month with free shipping ...
U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results